NasdaqGS:SHCLife Sciences
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year
Sotera Health reported its fourth-quarter and full-year 2025 results on February 24, 2026, with revenue rising to US$303.44 million for the quarter and US$1.16 billion for the year, alongside higher net income and earnings per share.
The company also issued 2026 revenue guidance of US$1.23 billion to US$1.25 billion and marked its 20th consecutive year of revenue growth, underscoring consistent demand for its sterilization and lab testing services.
Next, we’ll examine how Sotera Health’s...